Fresenius | FRE - Gross Profit On Sales

Stock Price
44.45
Daily Change
-1.60 -3.47%
Monthly
-14.62%
Yearly
12.36%
Q1 Forecast
45.46

Fresenius reported EUR1.51B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Akzo Nobel EUR 1.04B 10M Jun/2025
Alcon AG USD 1.52B 58M Dec/2025
AstraZeneca USD 12.39B 5M Dec/2025
BASF EUR 3.11B 55M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
DaVita Healthcare Partners USD 1.02B 63.9M Dec/2025
Demant DKK 8.82B 277M Dec/2025
E.ON EUR 4.63B 663M Sep/2025
Essilor EUR 8.3B 547M Dec/2025
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.39B 147M Dec/2025
Getinge SEK 5.05B 1.5B Dec/2024
Givaudan CHF 823M 575M Jun/2024
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GN Store Nord DKK 2.5B 344M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 2.96B 252M Dec/2025
Novartis USD 10.82B 695M Sep/2025
Philips EUR 2.29B 377M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
RWE EUR 723M 820M Sep/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025